Given that higher LY doses were utilized in this study compared to our previous experiment [14], this differential in the onset of correction of hyperglycemia raises the possibility that greater doses of FGF21 and/or use of FGF21 variants with improved potency may offer a more rapid and sustainable therapeutic response. This evidence concerns the gene FGF21 and Hyperglycemia.